Thank you for asking! Here is the answer. Your QUESTION is horesepuckey. Clearly no one cares. What is so important about fragile X? NTRP scientists, management, made a decision to focus resources on where they believed the science leads the process. If a decision internally to abandon or delay or reposition Fragile X, good for them. Do it! If investors do not trust management decisions I always recommend they petition to have management removed. I for one trust the team. thats why I am an investor.
Give NTRP a break. They have been very busy failing two P2 trials in AD, which no mean feat. They will eventually get round to failing Fragile X too just needs a little more dilution over the next few years.